6524 |
SOLUTE CARRIER FAMILY 5 MEMBER 2 |
SLC5A2 |
SGLT2 |
182381 |
11037 |
ENSG00000140675 |
OTTHUMG00000176620 |
P31639 |
SODIUM/GLUCOSE COTRANSPORTER 2 |
NA(+)/GLUCOSE COTRANSPORTER 2 |
LOW AFFINITY SODIUM-GLUCOSE COTRANSPORTER |
SODIUM/GLUCOSE COTRANSPORTER 2 (NA(+)/GLUCOSE COTRANSPORTER 2) (LOW AFFINITY SODIUM-GLUCOSE COTRANSPORTER). [SOURCE:UNIPROT/SWISSPROT;ACC:P31639] |
Q9HAB3 |
Target Class | Transporters |
Target Subclass | TC:2.A.21.3.16 |
Human Readable Name | DRUGGABLE GENOME |
Target Class | Transporter |
Target Subclass | TC:9.A.53.1.3 |
Gene Biotype | PROTEIN_CODING |
TRANSPORTER |
EXTERNAL SIDE OF PLASMA MEMBRANE |
DRUGGABLE GENOME |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Trial Name | BI-10773 |
Novel drug target | Established target |
Mechanism of Interaction | Sodium/glucose cotransporter 2 inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium/glucose cotransporter 2 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium/glucose cotransporter 2 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium/glucose cotransporter 2 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium/glucose cotransporter 2 inhibitor |
Direct Interaction | yes |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | BMS-512148, dapagliflozin |
inhibitor (inhibitory) |
Trial Name | ASP1941 |
Novel drug target | Established target |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium/glucose cotransporter 2 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | Canagliflozin |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium/glucose cotransporter 2 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium/glucose cotransporter 2 inhibitor |
Direct Interaction | yes |
n/a |
Trial Name | Glufosfamide |
Novel drug target | Established target |
SLC5A2 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
SLC5A2 | Display Id |
SODIUM/GLUCOSE COTRANSPORTER 2 (NA(+)/GLUCOSE COTRANSPORTER 2) (LOW AFFINITY SODIUM-GLUCOSE COTRANSPORTER). [SOURCE:UNIPROT/SWISSPROT;ACC:P31639] | Description |
ENSG00000140675 | Ensembl Gene Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
SLC5A2 | Gene Symbol |
Target Class | Transporter |
Target Subclass | TC:9.A.53.1.3 |
SLC5A2 | Gene Symbol |
Target Class | Transporters |
Target Subclass | TC:2.A.21.3.16 |
SGLT2 | GENE_SYMBOL |
SLC5A2 | GENE_SYMBOL |
Sodium/glucose cotransporter 2 | UNIPROT |
ENSG00000140675 | Gene Symbol |
SLC5A2 | Ensembl Id |
DRUGGABLE GENOME |
SGLT2 | GO Gene Synonym |
EXTERNAL SIDE OF PLASMA MEMBRANE |
Sodium/glucose cotransporter 2 | Gene Name |
P31639 | UniProt ID |
TRANSPORTER |